Gator Psychiatry

Post by EASO on X Infograph obesity facts

EASO

⁦‪@EASOobesity‬⁩

Obesity: The Hard Facts

23% of adults were estimated to have obesity in the EU in 2016.

Obesity is the No.1 independent cause of premature mortality.

10-13% of deaths in parts of Europe are linked to obesity.

Treat obesity the same way as other NCDs.
easo.org/policy/ pic.twitter.com/zwBH4V1WuK

8/28/24, 2:32 AM

Joseph Thornton

Post by JAMA Psychiatry on X. Boaters psychosis in dementia

JAMA Psychiatry

⁦‪@JAMAPsych‬⁩

Plasma levels of p-tau181 and NfL may be used as a biomarker for psychosis in mild cognitive impairment and Alzheimer disease, with potential implications for disease monitoring and treatment strategies. ja.ma/46A3Oz1

8/27/24, 6:00 AM

Joseph Thornton

Post by Norman Fixel Institute for Neurological Diseases on X

Norman Fixel Institute for Neurological Diseases

⁦‪@FixelInstitute‬⁩

New research from Fixel and UF Health reveals a promising link between GLP-1 receptor agonists and a reduced risk of Parkinson’s in older adults with type 2 diabetes. The study found a 23% lower risk of PD among GLP-1RA users compared to DPP4i users.
🔗: …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md… pic.twitter.com/ymXGUgCv5v

8/27/24, 3:30 PM

Joseph Thornton

Post by Michael Okun on X. GLP 1 prevent Parkinson’s

Michael Okun

⁦‪@MichaelOkun‬⁩

Do glucagon-like peptide-1 receptor agonists (GLP-1’s) reduce the risk of later Parkinson’s disease in type 2 diabetes? Tang and colleagues ⁦‪@FixelInstitute‬⁩ ⁦‪@UFPharmacy‬⁩ take apart this question in a new paper published in the ⁦‪@MDJ_Journal‬⁩. Do you know where the term ‘let the cat… pic.twitter.com/sznpogiqIX

8/27/24, 8:50 AM

Joseph Thornton

Post by deprescribing.org. Evidenced based tools for individualized care

deprescribing.org

⁦‪@deprescribing‬⁩

⁦‪@AmyTPage‬⁩ ⁦‪@KennyPharmPhD‬⁩ ⁦‪@drhurwitz87‬⁩ ⁦‪@DeprescribeAU‬⁩ Check out our evidence-based tools that can guide patient-specific #Deprescribing interventions!
buff.ly/48I6Ph9

8/24/24, 12:00 PM

Joseph Thornton

Semaglutide in Psychiatry—Opportunities and Challenges | Diabetes | JAMA Psychiatry | JAMA Network

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2822341

Joseph Thornton

Post by JAMA on infographic obesity rx

JAMA

⁦‪@JAMA_current‬⁩

Obesity is associated with multiple comorbidities. This review examines the safety and efficacy of antiobesity medications in conjunction with lifestyle modification according to their mechanism of action. ja.ma/3MgehWZ pic.twitter.com/xPYwYE7clS

8/24/24, 8:00 AM

Joseph Thornton

Post by Awais Aftab on diagnostic frameworks with Allen Frances

Awais Aftab

⁦‪@awaisaftab‬⁩

Psychiatric Diagnosis: A Clinical Guide to Navigating Diagnostic Pluralism

New publication by me, ⁦‪@Castalia1981‬⁩, ⁦‪@MarkLRuffalo‬⁩, & ⁦‪@AllenFrancesMD‬⁩! Focus is on helping clinicians navigate the current plurality of diagnostic frameworks (pdf 🔗in posts 👇)

journals.lww.com/jonmd/abstract… pic.twitter.com/HFvmh9OHaS

7/30/24, 3:38 PM

Joseph Thornton

Post by The Lancet on X. Suicide prevention

The Lancet

⁦‪@TheLancet‬⁩

This #WorldSuicidePreventionDay, attend a webinar about a new Lancet Public Health Series.

📌 In partnership with the International Association for Suicide Prevention (⁦‪@IASPinfo‬⁩) pic.twitter.com/oRHVgQIbUb

8/22/24, 12:07 PM

Joseph Thornton

Post by Yuhao ‘Danny. NATURE review. Theta burst TMS

Yuhao ‘Danny’ Huang, MD

⁦‪@YuhaoHuangMD‬⁩

Theta-burst stim (TBS) is used to treat depression, but how does it work? I dug into this question in my research yr with ⁦‪@DrCoreyKeller‬⁩ ⁦‪@ACPaulk‬⁩, now out in ⁦‪@NatureComms‬⁩, finding that TBS can produce plasticity-like changes in just minutes of stim. nature.com/articles/s4146… pic.twitter.com/XZq77F0zcn

8/15/24, 10:23 AM

Joseph Thornton